Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2e3
|
ENSMUSG00000032292.2 | nuclear receptor subfamily 2, group E, member 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_59948586_59948744 | Nr2e3 | 126 | 0.936107 | -0.21 | 1.2e-01 | Click! |
chr9_59959367_59959619 | Nr2e3 | 1162 | 0.345498 | -0.01 | 9.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_129533069_129533908 | 11.32 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
63 |
0.68 |
chr9_37359459_37360109 | 11.20 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chrX_49288183_49288615 | 10.42 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
140 |
0.97 |
chr14_80901414_80901614 | 10.27 |
Gm49044 |
predicted gene, 49044 |
29223 |
0.21 |
chr9_121366889_121367209 | 10.24 |
Trak1 |
trafficking protein, kinesin binding 1 |
33 |
0.97 |
chr9_75683480_75683688 | 10.24 |
Scg3 |
secretogranin III |
3 |
0.97 |
chr16_77852087_77852674 | 9.85 |
Gm17333 |
predicted gene, 17333 |
5776 |
0.27 |
chr10_96398607_96398834 | 8.85 |
Gm20091 |
predicted gene, 20091 |
10318 |
0.2 |
chr4_21932308_21932628 | 8.73 |
Faxc |
failed axon connections homolog |
1111 |
0.54 |
chr2_125032103_125032272 | 8.70 |
Slc24a5 |
solute carrier family 24, member 5 |
35937 |
0.16 |
chr3_154817331_154817637 | 8.31 |
Gm18589 |
predicted gene, 18589 |
22123 |
0.2 |
chr2_69418258_69418920 | 8.16 |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
38144 |
0.15 |
chr10_34316564_34316763 | 8.13 |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
2980 |
0.17 |
chr13_52562127_52562509 | 7.83 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr4_134496569_134497650 | 7.72 |
Paqr7 |
progestin and adipoQ receptor family member VII |
68 |
0.95 |
chr11_80503692_80504063 | 7.63 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
5229 |
0.22 |
chr7_131628906_131629291 | 7.62 |
Gm16477 |
predicted pseudogene 16477 |
14110 |
0.17 |
chr2_11391722_11392142 | 7.53 |
8030442B05Rik |
RIKEN cDNA 8030442B05 gene |
6569 |
0.1 |
chr15_103518626_103518966 | 7.30 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
3876 |
0.17 |
chr13_84345805_84346434 | 7.23 |
Gm26927 |
predicted gene, 26927 |
6006 |
0.25 |
chr6_58932915_58933165 | 7.17 |
Herc3 |
hect domain and RLD 3 |
25778 |
0.12 |
chr12_107952275_107952669 | 7.17 |
Bcl11b |
B cell leukemia/lymphoma 11B |
50942 |
0.16 |
chr6_8956269_8957017 | 7.11 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr14_68923045_68923441 | 7.08 |
Gm47256 |
predicted gene, 47256 |
48408 |
0.15 |
chr14_66344863_66345100 | 7.07 |
Stmn4 |
stathmin-like 4 |
600 |
0.71 |
chr7_63956761_63957700 | 6.84 |
Gm45052 |
predicted gene 45052 |
5010 |
0.15 |
chr3_17788774_17789074 | 6.79 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
997 |
0.54 |
chr2_14535423_14535658 | 6.76 |
Gm13266 |
predicted gene 13266 |
22941 |
0.16 |
chr1_46829988_46830169 | 6.72 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5821 |
0.22 |
chr15_44706767_44707004 | 6.64 |
Sybu |
syntabulin (syntaxin-interacting) |
40903 |
0.15 |
chr9_56738591_56739084 | 6.55 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
30286 |
0.16 |
chr1_31233663_31234000 | 6.54 |
Pih1d3 |
PIH1 domain containing 3 |
10993 |
0.12 |
chr7_87586675_87586826 | 6.54 |
Grm5 |
glutamate receptor, metabotropic 5 |
2352 |
0.42 |
chr1_12410598_12410778 | 6.53 |
Mir6341 |
microRNA 6341 |
15298 |
0.24 |
chrX_67304896_67305266 | 6.52 |
Gm8312 |
predicted gene 8312 |
134851 |
0.05 |
chr2_132751876_132752082 | 6.52 |
Chgb |
chromogranin B |
29299 |
0.1 |
chrX_110584674_110584875 | 6.49 |
Gm14886 |
predicted gene 14886 |
19723 |
0.21 |
chr18_45014470_45014883 | 6.45 |
Gm31706 |
predicted gene, 31706 |
30186 |
0.16 |
chr2_115460480_115461045 | 6.41 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
51439 |
0.15 |
chr13_59091457_59091627 | 6.34 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
7449 |
0.18 |
chr5_28467052_28467220 | 6.30 |
Shh |
sonic hedgehog |
120 |
0.54 |
chr3_34642307_34643037 | 6.29 |
Gm42692 |
predicted gene 42692 |
592 |
0.6 |
chr6_71126381_71126688 | 6.25 |
Rpl34-ps1 |
ribosomal protein L34, pseudogene 1 |
1924 |
0.24 |
chr6_66399103_66399403 | 6.23 |
Gm44233 |
predicted gene, 44233 |
507 |
0.47 |
chr12_3238767_3239202 | 6.23 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
chr1_66320866_66321435 | 6.22 |
Map2 |
microtubule-associated protein 2 |
569 |
0.75 |
chr3_73056881_73057482 | 6.22 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr18_35214941_35215148 | 6.15 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
20 |
0.56 |
chr2_152049814_152050498 | 6.15 |
AA387200 |
expressed sequence AA387200 |
26652 |
0.12 |
chr14_103764083_103764411 | 6.10 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
64805 |
0.11 |
chr16_7146478_7146815 | 6.09 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
47101 |
0.21 |
chr14_45388403_45389548 | 6.08 |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
14 |
0.96 |
chr13_5728919_5729070 | 6.07 |
Gm35330 |
predicted gene, 35330 |
4484 |
0.3 |
chr10_59957812_59958054 | 6.07 |
Ddit4 |
DNA-damage-inducible transcript 4 |
6099 |
0.19 |
chr10_41934443_41935500 | 6.03 |
Sesn1 |
sestrin 1 |
36598 |
0.15 |
chr1_21411663_21411841 | 5.99 |
Gm16328 |
predicted gene 16328 |
20846 |
0.1 |
chr3_88230737_88231417 | 5.97 |
Gm3764 |
predicted gene 3764 |
2294 |
0.13 |
chr14_84446496_84447465 | 5.94 |
Pcdh17 |
protocadherin 17 |
1527 |
0.47 |
chr4_56089046_56089235 | 5.92 |
Gm12520 |
predicted gene 12520 |
73800 |
0.11 |
chr5_46790646_46790887 | 5.92 |
Gm43092 |
predicted gene 43092 |
3914 |
0.38 |
chr10_106469114_106469265 | 5.90 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
1150 |
0.52 |
chr3_17619540_17619872 | 5.88 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr13_116497636_116498069 | 5.83 |
Gm47912 |
predicted gene, 47912 |
136158 |
0.05 |
chr3_107114477_107114841 | 5.80 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11977 |
0.14 |
chr16_64068866_64069083 | 5.80 |
Gm49627 |
predicted gene, 49627 |
113844 |
0.07 |
chr13_83739197_83739995 | 5.76 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr6_55920513_55920755 | 5.75 |
Itprid1 |
ITPR interacting domain containing 1 |
33809 |
0.21 |
chr18_78455617_78455793 | 5.74 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21173 |
0.24 |
chr9_58457547_58457755 | 5.71 |
4930461G14Rik |
RIKEN cDNA 4930461G14 gene |
2529 |
0.27 |
chr15_44836696_44836899 | 5.69 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
44622 |
0.14 |
chr1_172014833_172015030 | 5.69 |
Vangl2 |
VANGL planar cell polarity 2 |
5902 |
0.15 |
chr4_33697059_33697234 | 5.65 |
Gm24341 |
predicted gene, 24341 |
15655 |
0.25 |
chr4_91092301_91092748 | 5.64 |
Gm12643 |
predicted gene 12643 |
54624 |
0.14 |
chr10_87309787_87309961 | 5.61 |
Gm10764 |
predicted gene 10764 |
19141 |
0.2 |
chr6_115126272_115126705 | 5.59 |
Gm17733 |
predicted gene, 17733 |
8347 |
0.14 |
chr9_64621699_64621949 | 5.58 |
Megf11 |
multiple EGF-like-domains 11 |
38635 |
0.17 |
chr14_8511508_8511673 | 5.57 |
Gm8416 |
predicted gene 8416 |
102673 |
0.06 |
chr1_29217161_29217338 | 5.57 |
Gm18033 |
predicted gene, 18033 |
2451 |
0.41 |
chr7_62046082_62046717 | 5.55 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr3_9654474_9654670 | 5.53 |
Gm17806 |
predicted gene, 17806 |
1948 |
0.37 |
chr13_18281120_18281485 | 5.52 |
Pou6f2 |
POU domain, class 6, transcription factor 2 |
94816 |
0.08 |
chr6_91839831_91839982 | 5.52 |
Grip2 |
glutamate receptor interacting protein 2 |
12656 |
0.15 |
chr12_58512603_58512786 | 5.47 |
Clec14a |
C-type lectin domain family 14, member a |
243404 |
0.02 |
chr6_17796921_17797464 | 5.44 |
Gm26738 |
predicted gene, 26738 |
37993 |
0.12 |
chr19_26770137_26770516 | 5.44 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr12_48222098_48222420 | 5.42 |
Gm46327 |
predicted gene, 46327 |
174725 |
0.03 |
chr17_50006411_50007013 | 5.37 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
33885 |
0.17 |
chr5_65003074_65003225 | 5.30 |
Gm43627 |
predicted gene 43627 |
30499 |
0.11 |
chr4_97581822_97582075 | 5.29 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
2648 |
0.32 |
chr2_44299262_44299453 | 5.25 |
Gm22867 |
predicted gene, 22867 |
129578 |
0.06 |
chr9_41697271_41698297 | 5.25 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr18_42163861_42164012 | 5.21 |
Cstdc7 |
cystatin domain containing 7 |
9434 |
0.13 |
chr1_132542826_132543135 | 5.21 |
Cntn2 |
contactin 2 |
41 |
0.97 |
chr1_85588537_85589247 | 5.19 |
Sp110 |
Sp110 nuclear body protein |
299 |
0.81 |
chr9_27454354_27454543 | 5.19 |
Spata19 |
spermatogenesis associated 19 |
56923 |
0.12 |
chr12_50999736_51000192 | 5.18 |
Gm40421 |
predicted gene, 40421 |
4909 |
0.23 |
chr13_113226153_113226334 | 5.17 |
Gzmk |
granzyme K |
335 |
0.87 |
chr2_49672278_49672906 | 5.17 |
Gm13525 |
predicted gene 13525 |
7907 |
0.24 |
chr9_41579443_41579641 | 5.17 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
48 |
0.95 |
chr10_116018524_116018900 | 5.15 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
425 |
0.9 |
chr1_18058368_18058994 | 5.13 |
Gm28756 |
predicted gene 28756 |
109 |
0.82 |
chr4_57433554_57433766 | 5.13 |
Pakap |
paralemmin A kinase anchor protein |
587 |
0.73 |
chr7_64539337_64539734 | 5.13 |
Gm44721 |
predicted gene 44721 |
10110 |
0.19 |
chr13_83725778_83725984 | 5.12 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2225 |
0.21 |
chr4_65838866_65839193 | 5.08 |
Trim32 |
tripartite motif-containing 32 |
233780 |
0.02 |
chr8_12135810_12136025 | 5.08 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
142902 |
0.04 |
chr5_65950335_65950545 | 5.07 |
4930480C01Rik |
RIKEN cDNA 4930480C01 gene |
865 |
0.45 |
chr3_126723256_126723448 | 5.07 |
Gm42515 |
predicted gene 42515 |
14145 |
0.14 |
chr8_112569720_112569921 | 5.07 |
Cntnap4 |
contactin associated protein-like 4 |
223 |
0.52 |
chr11_3132475_3133419 | 5.05 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3060 |
0.17 |
chr13_80615097_80615248 | 5.05 |
Gm46388 |
predicted gene, 46388 |
122163 |
0.06 |
chr17_41227772_41227923 | 5.03 |
Gm6771 |
predicted gene 6771 |
118150 |
0.05 |
chr12_51002470_51002650 | 5.02 |
Gm40421 |
predicted gene, 40421 |
2313 |
0.29 |
chr19_28381061_28381212 | 5.02 |
Glis3 |
GLIS family zinc finger 3 |
55130 |
0.16 |
chr4_66401138_66401430 | 5.01 |
Astn2 |
astrotactin 2 |
3199 |
0.35 |
chr17_88316794_88316983 | 4.99 |
1700116H05Rik |
RIKEN cDNA 1700116H05 gene |
10001 |
0.19 |
chr8_104590953_104591575 | 4.99 |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
187 |
0.89 |
chr8_54954036_54954355 | 4.99 |
Gpm6a |
glycoprotein m6a |
648 |
0.67 |
chr4_40375544_40375695 | 4.98 |
4930509K18Rik |
RIKEN cDNA 4930509K18 gene |
62387 |
0.09 |
chr16_73108130_73108317 | 4.98 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
9235 |
0.31 |
chr4_151141102_151141464 | 4.98 |
Camta1 |
calmodulin binding transcription activator 1 |
1699 |
0.42 |
chr5_149831493_149831699 | 4.97 |
4930500F04Rik |
RIKEN cDNA 4930500F04 gene |
16151 |
0.15 |
chr9_60460386_60460571 | 4.95 |
Thsd4 |
thrombospondin, type I, domain containing 4 |
36648 |
0.12 |
chr17_55367602_55367789 | 4.94 |
Gm49921 |
predicted gene, 49921 |
21012 |
0.2 |
chr4_36369079_36369233 | 4.93 |
Gm12370 |
predicted gene 12370 |
74914 |
0.12 |
chr8_49998733_49998921 | 4.92 |
Gm45324 |
predicted gene 45324 |
8920 |
0.24 |
chr18_7484600_7484751 | 4.91 |
Mpp7 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
18502 |
0.23 |
chr16_74225730_74225959 | 4.90 |
Gm18021 |
predicted gene, 18021 |
23049 |
0.18 |
chr4_47225987_47226270 | 4.90 |
Col15a1 |
collagen, type XV, alpha 1 |
7139 |
0.2 |
chr3_9173889_9174631 | 4.87 |
Zbtb10 |
zinc finger and BTB domain containing 10 |
76342 |
0.09 |
chr4_82946256_82946439 | 4.87 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
5465 |
0.26 |
chr12_50851723_50851891 | 4.86 |
Gm48777 |
predicted gene, 48777 |
43664 |
0.18 |
chr16_43508766_43508917 | 4.85 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
578 |
0.81 |
chr4_76365995_76366146 | 4.85 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
21827 |
0.21 |
chr5_20751911_20752076 | 4.83 |
Phtf2 |
putative homeodomain transcription factor 2 |
22120 |
0.16 |
chr2_22029112_22029317 | 4.83 |
Gm13337 |
predicted gene 13337 |
38612 |
0.22 |
chr16_76827786_76827960 | 4.82 |
1700063K16Rik |
RIKEN cDNA 1700063K16 gene |
6132 |
0.24 |
chr5_71701314_71701508 | 4.82 |
Gabrb1 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 1 |
1479 |
0.35 |
chr8_16014546_16014738 | 4.80 |
Csmd1 |
CUB and Sushi multiple domains 1 |
29830 |
0.23 |
chrX_53607803_53608436 | 4.80 |
Rtl8c |
retrotransposon Gag like 8C |
87 |
0.92 |
chr19_27599750_27599901 | 4.79 |
Gm50101 |
predicted gene, 50101 |
87317 |
0.09 |
chr19_41725107_41725290 | 4.78 |
Slit1 |
slit guidance ligand 1 |
18288 |
0.2 |
chr10_12725144_12725295 | 4.77 |
Utrn |
utrophin |
36357 |
0.19 |
chr14_95877129_95877467 | 4.77 |
Spertl |
spermatid associated like |
3956 |
0.31 |
chr14_101494013_101494504 | 4.77 |
Tbc1d4 |
TBC1 domain family, member 4 |
6850 |
0.27 |
chr6_8956056_8956243 | 4.76 |
Nxph1 |
neurexophilin 1 |
6473 |
0.33 |
chr19_33391464_33392505 | 4.76 |
Rnls |
renalase, FAD-dependent amine oxidase |
281 |
0.91 |
chr1_47164093_47164266 | 4.75 |
Gm28826 |
predicted gene 28826 |
10718 |
0.28 |
chr3_55415517_55415960 | 4.75 |
Gm42609 |
predicted gene 42609 |
12616 |
0.17 |
chr5_38886717_38886877 | 4.73 |
Clnk |
cytokine-dependent hematopoietic cell linker |
9985 |
0.28 |
chr4_87739796_87740016 | 4.72 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
66388 |
0.14 |
chr2_63452968_63453186 | 4.70 |
Gm23503 |
predicted gene, 23503 |
20883 |
0.24 |
chr8_47345606_47345761 | 4.70 |
Stox2 |
storkhead box 2 |
6665 |
0.26 |
chr10_46827266_46827417 | 4.68 |
Gm25650 |
predicted gene, 25650 |
11166 |
0.24 |
chr5_90603507_90603737 | 4.68 |
Rassf6 |
Ras association (RalGDS/AF-6) domain family member 6 |
6179 |
0.16 |
chr3_26003308_26003504 | 4.67 |
Nlgn1 |
neuroligin 1 |
130328 |
0.06 |
chr16_70725367_70725548 | 4.66 |
Gm49665 |
predicted gene, 49665 |
22265 |
0.23 |
chr3_28558287_28558936 | 4.66 |
Tnik |
TRAF2 and NCK interacting kinase |
20333 |
0.24 |
chr3_55241817_55241968 | 4.65 |
Dclk1 |
doublecortin-like kinase 1 |
472 |
0.82 |
chr16_5766788_5767000 | 4.64 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
118461 |
0.06 |
chr10_37378360_37378791 | 4.64 |
Gm26535 |
predicted gene, 26535 |
41089 |
0.18 |
chr14_49782829_49783231 | 4.64 |
Armh4 |
armadillo-like helical domain containing 4 |
341 |
0.83 |
chr1_14755119_14756069 | 4.63 |
Gm9947 |
predicted gene 9947 |
140 |
0.64 |
chr5_16002604_16003015 | 4.63 |
Gm43000 |
predicted gene 43000 |
4970 |
0.22 |
chr18_43687033_43687193 | 4.63 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
512 |
0.82 |
chr12_79911112_79911786 | 4.62 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
13284 |
0.2 |
chr14_64595318_64595919 | 4.62 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr2_71536347_71536513 | 4.59 |
Dlx1as |
distal-less homeobox 1, antisense |
1380 |
0.33 |
chr1_89739598_89739966 | 4.58 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
49381 |
0.14 |
chr3_34638120_34638287 | 4.58 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
29 |
0.77 |
chr2_63962810_63962988 | 4.58 |
Fign |
fidgetin |
135089 |
0.06 |
chr18_46748165_46748456 | 4.58 |
Ap3s1 |
adaptor-related protein complex 3, sigma 1 subunit |
6368 |
0.12 |
chr4_100945474_100945811 | 4.58 |
Cachd1 |
cache domain containing 1 |
48969 |
0.14 |
chr4_82532408_82532766 | 4.57 |
Gm11266 |
predicted gene 11266 |
24571 |
0.17 |
chr12_50120364_50120537 | 4.57 |
Gm40418 |
predicted gene, 40418 |
141 |
0.98 |
chr6_94631038_94631254 | 4.57 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
24379 |
0.17 |
chr8_12916060_12916211 | 4.56 |
Mcf2l |
mcf.2 transforming sequence-like |
160 |
0.73 |
chr18_9001390_9001541 | 4.56 |
Gm7523 |
predicted gene 7523 |
33721 |
0.19 |
chr2_11765906_11766082 | 4.56 |
Fbh1 |
F-box DNA helicase 1 |
7521 |
0.18 |
chr2_66041591_66042392 | 4.55 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
52080 |
0.12 |
chr14_47911761_47912146 | 4.55 |
4930447J18Rik |
RIKEN cDNA 4930447J18 gene |
13044 |
0.17 |
chr5_58740846_58740997 | 4.54 |
Gm43394 |
predicted gene 43394 |
260072 |
0.02 |
chr15_83998515_83998666 | 4.54 |
Efcab6 |
EF-hand calcium binding domain 6 |
9608 |
0.2 |
chr3_79416721_79416872 | 4.52 |
Fnip2 |
folliculin interacting protein 2 |
49409 |
0.13 |
chr6_19283048_19283211 | 4.51 |
4930524B17Rik |
RIKEN cDNA 4930524B17 gene |
4286 |
0.3 |
chr2_65826757_65826932 | 4.50 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
18923 |
0.19 |
chr12_107285742_107285893 | 4.49 |
Gm5187 |
predicted gene 5187 |
79751 |
0.09 |
chr13_6131432_6131800 | 4.49 |
Gm47548 |
predicted gene, 47548 |
57834 |
0.13 |
chr9_61468686_61468864 | 4.47 |
Gm47240 |
predicted gene, 47240 |
4211 |
0.22 |
chr3_55352072_55352270 | 4.46 |
Dclk1 |
doublecortin-like kinase 1 |
1963 |
0.31 |
chr4_81566140_81566319 | 4.45 |
Gm11765 |
predicted gene 11765 |
104497 |
0.07 |
chr3_39048045_39048216 | 4.44 |
Gm43539 |
predicted gene 43539 |
38449 |
0.19 |
chr11_47343450_47343810 | 4.44 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
35892 |
0.23 |
chr4_55929179_55929426 | 4.41 |
Gm12519 |
predicted gene 12519 |
64437 |
0.14 |
chr13_77490374_77490545 | 4.41 |
Gm9634 |
predicted gene 9634 |
63914 |
0.14 |
chr1_63876695_63876846 | 4.38 |
Gm13751 |
predicted gene 13751 |
31192 |
0.16 |
chr3_69708942_69709095 | 4.36 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
8375 |
0.17 |
chr12_50943440_50943626 | 4.35 |
Gm48777 |
predicted gene, 48777 |
48062 |
0.14 |
chr13_60051160_60051402 | 4.35 |
Gm48396 |
predicted gene, 48396 |
6344 |
0.17 |
chr4_17852942_17853620 | 4.35 |
Mmp16 |
matrix metallopeptidase 16 |
177 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.8 | 5.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.7 | 5.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.5 | 13.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.4 | 5.8 | GO:0030035 | microspike assembly(GO:0030035) |
1.4 | 4.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.4 | 4.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.4 | 4.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.4 | 1.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.4 | 4.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.4 | 4.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.3 | 5.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.3 | 1.3 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.3 | 5.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.2 | 8.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.2 | 6.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.2 | 4.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.1 | 4.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.1 | 5.4 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.1 | 3.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.1 | 3.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.0 | 5.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.0 | 6.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.0 | 4.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.0 | 3.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.0 | 4.0 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 4.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 1.9 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.9 | 2.8 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.9 | 0.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.9 | 9.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 3.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 2.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 2.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.9 | 4.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.9 | 6.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.8 | 11.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.8 | 2.5 | GO:0033058 | directional locomotion(GO:0033058) |
0.8 | 2.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.8 | 3.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.8 | 19.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 2.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 2.5 | GO:0046959 | habituation(GO:0046959) |
0.8 | 2.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.8 | 2.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.8 | 2.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.8 | 3.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 7.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.8 | 3.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.8 | 2.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.8 | 2.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 5.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 2.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 4.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 2.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 3.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.7 | 1.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.7 | 2.7 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 1.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.7 | 1.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 0.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.6 | 0.6 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.6 | 1.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.6 | 1.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.6 | 1.9 | GO:0043366 | beta selection(GO:0043366) |
0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 1.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.6 | 1.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 2.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 1.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 1.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.6 | 2.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.6 | 1.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.6 | 1.7 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 0.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.6 | 1.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.6 | 7.2 | GO:0001553 | luteinization(GO:0001553) |
0.6 | 1.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 3.3 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.5 | 3.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.5 | 2.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.5 | 2.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 2.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 5.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 7.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 3.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 1.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 1.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 3.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.5 | 1.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 1.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.5 | 2.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 3.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 28.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 1.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 1.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 1.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 0.9 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.5 | 5.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.5 | 1.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 2.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 2.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 0.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.4 | 2.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 1.8 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.4 | 3.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 3.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 1.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 3.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 0.9 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.4 | 0.4 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.4 | 1.7 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.4 | 0.9 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.4 | 0.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 3.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 0.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 2.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 2.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 1.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 2.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 1.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 1.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 2.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 0.8 | GO:1901671 | regulation of superoxide dismutase activity(GO:1901668) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.4 | 0.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.4 | 2.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 2.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.4 | 2.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 1.5 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 4.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 1.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 0.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 1.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.4 | 1.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.9 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.4 | 3.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.4 | 2.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 1.5 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 1.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 3.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 1.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 3.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.4 | 11.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 2.6 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.4 | 1.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 1.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 1.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 1.8 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 0.4 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.4 | 0.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 0.7 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 4.9 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 1.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 2.8 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 1.4 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.3 | 0.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.3 | 13.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 2.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 1.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 1.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 2.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 1.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.3 | 1.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.3 | 1.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 1.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 1.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 1.9 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.3 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 2.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 1.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 3.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 0.6 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 0.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.9 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.3 | 2.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 3.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.7 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.3 | 1.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 1.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 1.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 4.3 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.3 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 0.9 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 1.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 3.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 2.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.5 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.3 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 0.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 | 2.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.8 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.3 | 0.8 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.3 | 1.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 1.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.5 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.3 | 1.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 6.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.3 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 4.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.8 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.7 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 1.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 1.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.2 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.5 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 3.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.2 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.2 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 2.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.7 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 1.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.4 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
0.2 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 3.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 6.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 2.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 3.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 0.6 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.4 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.2 | 0.2 | GO:0072103 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 0.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 6.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.2 | 0.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.2 | 1.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 1.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 2.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 3.3 | GO:0030431 | sleep(GO:0030431) |
0.2 | 0.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 2.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.2 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.2 | 0.6 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.2 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.6 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 2.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 1.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.2 | 2.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 1.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 1.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 1.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.7 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 1.6 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 1.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 2.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 1.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.2 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
0.2 | 0.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 3.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 1.0 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 1.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.2 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 3.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 0.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.2 | GO:0090102 | cochlea development(GO:0090102) |
0.2 | 0.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.2 | 2.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.5 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.2 | 3.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.2 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 1.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 3.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.3 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.6 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 1.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.1 | 1.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 1.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 1.3 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 8.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.6 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 1.4 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.1 | 0.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.9 | GO:2000671 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 1.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.8 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.4 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.1 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.7 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.1 | 3.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.6 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.3 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.1 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.1 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.3 | GO:0042558 | folic acid-containing compound metabolic process(GO:0006760) pteridine-containing compound metabolic process(GO:0042558) |
0.1 | 0.5 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 1.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 2.1 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.3 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.1 | 0.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.1 | 0.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 2.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.7 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 1.6 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.2 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.1 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.2 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.5 | GO:0072506 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.2 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.7 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.1 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.2 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 2.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.2 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0072124 | regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.0 | 0.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.0 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.0 | 1.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.0 | GO:0086067 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.0 | 0.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.0 | 0.0 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.2 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.0 | GO:0060073 | micturition(GO:0060073) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 1.6 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.0 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.7 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.5 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.4 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.5 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.0 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.0 | 0.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.0 | 0.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0046110 | purine nucleobase catabolic process(GO:0006145) xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:1902590 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.5 | 7.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 2.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.9 | 2.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.9 | 2.6 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.8 | 3.4 | GO:1990696 | USH2 complex(GO:1990696) |
0.8 | 7.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 2.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 5.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 2.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 2.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.6 | 1.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.6 | 9.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 31.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 3.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 1.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 8.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 9.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 2.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 4.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 3.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 2.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 1.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 2.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 10.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 1.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 1.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 7.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 2.0 | GO:0097433 | dense body(GO:0097433) |
0.4 | 3.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 6.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 2.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 2.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 5.2 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 1.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 9.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 2.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 1.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 14.4 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 1.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 0.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 0.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 5.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 4.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 3.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 2.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.1 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 3.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 2.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 3.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 2.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 21.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 1.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.1 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 1.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 13.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 9.2 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 3.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 2.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 3.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 4.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 3.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 19.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 1.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 3.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.6 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 3.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 4.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.7 | 8.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.6 | 3.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.4 | 4.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.2 | 3.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.2 | 4.8 | GO:0097001 | ceramide binding(GO:0097001) |
1.1 | 3.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 14.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.1 | 3.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.1 | 3.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.0 | 3.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.9 | 4.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.9 | 2.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 2.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.8 | 2.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.8 | 2.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.8 | 1.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 4.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 4.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 6.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.8 | 2.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.8 | 3.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 3.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.7 | 1.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.7 | 2.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.7 | 2.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 3.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 2.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.6 | 2.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.6 | 5.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 4.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 3.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 2.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.6 | 1.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 4.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 10.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 2.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 2.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 7.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 1.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 2.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 3.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 3.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 1.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 1.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 11.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.5 | 0.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 5.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 5.0 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 6.2 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.4 | 3.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 1.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 4.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 1.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 4.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 1.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 0.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 2.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 2.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 1.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.4 | 2.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.4 | 1.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 3.2 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 8.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 6.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 9.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 4.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 0.6 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.3 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 1.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 3.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 2.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 6.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 3.4 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.3 | 3.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 0.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 6.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 4.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 7.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 3.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 2.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 1.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 2.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 4.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 2.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 1.0 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 2.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 6.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 2.0 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.9 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.2 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 1.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 3.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 1.3 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.2 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 0.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 1.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 6.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 1.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.3 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 1.1 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 7.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 1.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 2.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 1.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 10.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.5 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 1.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 3.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.9 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 2.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 1.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 2.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 1.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.7 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.7 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 1.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 2.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.3 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.5 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 5.2 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 3.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 4.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 2.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 4.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 2.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 4.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 3.8 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 3.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 1.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.5 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.9 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 5.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.5 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.2 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.4 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.3 | GO:0043762 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.8 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.0 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.4 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.0 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.5 | GO:0080131 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 19.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 7.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 4.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 5.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 7.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 3.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 4.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 5.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 14.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 4.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 4.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 2.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 2.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 15.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 9.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.8 | 10.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 7.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 8.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 18.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 5.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 0.5 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.5 | 11.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 5.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 1.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 0.9 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 3.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 0.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 1.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 4.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 1.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.3 | 3.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 5.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 10.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 3.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 4.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 4.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 8.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 4.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 2.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 4.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 2.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 6.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 3.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 1.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 3.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |